/Companies

Guided Therapeutics

OTC: GTHP

Norcross, US · Delaware corporation · 1 known investors

Find your way into Guided Therapeutics

Sign up to see every warm intro you have to Guided Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Guided Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Guided Therapeutics develops medical devices based on patented biophotonic technology to detect diseases earlier, with its flagship LuViva Advanced Cervical Scan identifying tissue changes that are early signs of cervical cancer. The company sells to physicians and healthcare systems, with an international distribution presence including China.

Founders & leadership

MLMark L. Faupel
Mark L. FaupelFounder · President and CEO
RF
Rick FowlerVP Engineering
GSGene S. Cartwright
Gene S. CartwrightCEO2014–2023

Board

JE
John E. ImhoffBoard director
LR
Linda RosenstockBoard director
RW
Ronald W. HartBoard director
MC
Michael C. JamesBoard director
JM
Johnathan M. NiloffBoard director
JM
Jonathan M. NiloffBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$8.1M disclosed across 3 of 4 rounds · 2013–2021

▶$2.5MraisedJul 2015 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John E. ImhoffDirector
  • Linda RosenstockDirector
  • Ronald W. HartDirector
  • Michael C. JamesDirector
  • Rick FowlerExecutive Officer
  • Johnathan M. NiloffDirector
  • Gene S. CartwrightExecutive Officer, Director
Offering amount
$5.3M
Amount sold
$2.5M
Minimum investment
$25K
Sales commissions
$360K
Placement agents
Ladenburg Thalmann & Co. Inc.
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedMay 2014 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronald W. HartDirector
  • Mark L. FaupelDirector
  • Michael C. JamesDirector
  • John E. ImhoffDirector
  • Linda RosenstockDirector
  • Gene S. CartwrightExecutive Officer, Director
  • Jonathan M. NiloffDirector
Offering amount
$3M
Amount sold
$3M
Minimum investment
$1M
Proceeds to insiders
$3M
First sale
Apr 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Guided Therapeutics.

In the news

Frequently asked questions

What does Guided Therapeutics do?
Guided Therapeutics develops medical devices based on patented biophotonic technology to detect diseases earlier, with its flagship LuViva Advanced Cervical Scan identifying tissue changes that are early signs of cervical cancer. The company sells to physicians and healthcare systems, with an international distribution presence including China.
Who founded Guided Therapeutics?
Guided Therapeutics was founded by Mark L. Faupel.
Who are Guided Therapeutics's investors?
Guided Therapeutics's investors include The Whittemore Collection.
How much funding has Guided Therapeutics raised?
Guided Therapeutics has disclosed $8.1M raised across 3 of its 4 known rounds.
Where is Guided Therapeutics headquartered?
Guided Therapeutics is headquartered in Norcross, US.